Literature DB >> 33418996

Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells.

Marcin Domagala1,2,3, Chloé Laplagne1,2,3, Edouard Leveque1,2,3, Camille Laurent1,2,3,4, Jean-Jacques Fournié1,2,3, Eric Espinosa1,2,3, Mary Poupot1,2,3.   

Abstract

Interactions between malignant cells and neighboring stromal and immune cells profoundly shape cancer progression. New forms of therapies targeting these cells have revolutionized the treatment of cancer. However, in order to specifically address each population, it was essential to identify and understand their individual roles in interaction between malignant cells, and the formation of the tumor microenvironment (TME). In this review, we focus on the myeloid cell compartment, a prominent, and heterogeneous group populating TME, which can initially exert an anti-tumoral effect, but with time actively participate in disease progression. Macrophages, dendritic cells, neutrophils, myeloid-derived suppressor cells, mast cells, eosinophils, and basophils act alone or in concert to shape tumor cells resistance through cellular interaction and/or release of soluble factors favoring survival, proliferation, and migration of tumor cells, but also immune-escape and therapy resistance.

Entities:  

Keywords:  cancer development; microenvironment; myeloid cells; resistance

Year:  2021        PMID: 33418996     DOI: 10.3390/cancers13020165

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  6 in total

Review 1.  CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients.

Authors:  Fatih M Uckun; Justin Watts
Journal:  Front Aging       Date:  2021-09-27

2.  Why Target Innate Immune Cells in Cancers?

Authors:  Mary Poupot
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

3.  The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients.

Authors:  Jing Qi; Jiaqi Zhang; Xingping Ge; Xin Wang; Liming Xu; Ningbo Liu; Lujun Zhao; Ping Wang
Journal:  Front Oncol       Date:  2021-10-08       Impact factor: 6.244

Review 4.  Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance.

Authors:  Aiping Zhang; Kai Miao; Heng Sun; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2022-04-24       Impact factor: 10.750

Review 5.  Unraveling the Heterogeneity and Ontogeny of Dendritic Cells Using Single-Cell RNA Sequencing.

Authors:  Binyao Chen; Lei Zhu; Shizhao Yang; Wenru Su
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

6.  Phenotypic and Histological Distribution Analysis Identify Mast Cell Heterogeneity in Non-Small Cell Lung Cancer.

Authors:  Edouard Leveque; Axel Rouch; Charlotte Syrykh; Julien Mazières; Laurent Brouchet; Salvatore Valitutti; Eric Espinosa; Fanny Lafouresse
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.